Petra Hamerlík

Research activity per year

2019
Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC
Zhang, G., Bong, Z., Prager, B. C., Kim, L. J. K., Wu, Q., Gimple, R. C., Wang, X., Bao, S., Hamerlik, P. & Rich, J. N., 4 Apr 2019, In: JCI Insight. 4, 7, 20 p., e126140.
Research output: Contribution to journal › Journal article › Research
13 Citations (Scopus)
2018
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Staberg, M., Rasmussen, R. D., Michaelsen, S. R., Pedersen, H., Jensen, K. E., Villingshøj, M., Skjoth-Rasmussen, J., Brennum, J., Vitting-Seerup, K., Poulsen, H. S. & Hamerlik, P., Mar 2018, In: Molecular Oncology. 12, 3, p. 406-420 15 p.
Research output: Contribution to journal › Journal article › Research › peer-review
21 Citations (Scopus)

27 Downloads (Pure)
2017
Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
Staberg, M., Michaelsen, S. R., Rasmussen, R. D., Villingshøj, M., Poulsen, H. S. & Hamerlik, P., 1 Feb 2017, In: Cellular oncology (Dordrecht). 40, 1, p. 21-32 12 p.
Research output: Contribution to journal › Journal article › Research › peer-review
31 Citations (Scopus)

Research output